ALL KEYWORDSOptic Nerve Sheath MeningiomaRelated Clinical TrialsPhase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway MutationsBrain & Other Nervous System Cancers